Norquetiapine blocks the human cardiac sodium channel Na<inf>v</inf>1.5 in a state-dependent manner
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim | - |
dc.contributor.author | D.-H. | - |
dc.contributor.author | Park | - |
dc.contributor.author | K.-S. | - |
dc.contributor.author | Park, See-hyoung | - |
dc.contributor.author | S.-H. | - |
dc.contributor.author | Hahn | - |
dc.contributor.author | S.J. | - |
dc.contributor.author | Choi | - |
dc.contributor.author | J.-S. | - |
dc.date.available | 2021-03-17T07:48:26Z | - |
dc.date.created | 2021-02-26 | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 0014-2999 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/12536 | - |
dc.description.abstract | Quetiapine, an atypical antipsychotic drug, is used for the treatment of schizophrenia and acute mania. Although a previous report showed that quetiapine blocked hERG potassium current, quetiapine has been considered relatively safe in terms of cardiovascular side effects. In the present study, we used the whole-cell patch-clamp technique to investigate the effect that quetiapine and its major metabolite norquetiapine can exert on human cardiac sodium channels (hNa(v)1.5). The half-maximal inhibitory concentrations of quetiapine and norquetiapine at a holding potential of 90 mV near the resting potential of cardiomyocytes were 30 and 6 mu M, respectively. Norquetiapine as well as quetiapine was preferentially bound in the inactivated state of the hNa(v)1.5 channel. Norquetiapine slowed the recovery from inactivation of hNa(v)1.5 and consequently induced strong use-dependent inhibition. Our results indicate that norquetiapine blocks hNa(v)1.5 current in concentration-, state- and usedependent manners, suggesting that the blockade of hNa(v)1.5 current by norquetiapine may shorten the cardiac action potential duration and reduce the risk of QT interval prolongation induced by the inhibition of hERG potassium currents. | - |
dc.publisher | ELSEVIER | - |
dc.title | Norquetiapine blocks the human cardiac sodium channel Na<inf>v</inf>1.5 in a state-dependent manner | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, See-hyoung | - |
dc.identifier.doi | 10.1016/j.ejphar.2020.173532 | - |
dc.identifier.scopusid | 2-s2.0-85090214768 | - |
dc.identifier.wosid | 000629502900011 | - |
dc.identifier.bibliographicCitation | European Journal of Pharmacology, v.885 | - |
dc.relation.isPartOf | European Journal of Pharmacology | - |
dc.citation.title | European Journal of Pharmacology | - |
dc.citation.volume | 885 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordAuthor | Quetiapine | - |
dc.subject.keywordAuthor | Norquetiapine | - |
dc.subject.keywordAuthor | Voltage-gated sodium channel | - |
dc.subject.keywordAuthor | Na(v)1.5 | - |
dc.subject.keywordAuthor | Cardiac arrhythmia | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.